[Form 4] NEOGEN CORP Insider Trading Activity

Rhea-AI Filing Summary

Neogen (NEOG) reported an insider equity transaction by its CFO. On 11/03/2025, the officer acquired 178,855 shares of common stock at a stated price of $6.29, bringing directly held common shares to 178,855. The filing also shows a grant of stock options for 459,713 shares with an exercise price of $6.29.

According to the footnotes, the options vest in equal annual installments over three years from the grant date, while the performance stock units vest in total at the end of the three-year anniversary of the grant.

Insights

Corporate governance analyst

Routine executive equity grants with three-year vesting; neutral impact.

The CFO reported acquiring 178,855 common shares and receiving options for 459,713 shares at an exercise price of $6.29 on 11/03/2025. These figures reflect standard executive compensation structures that align pay with long-term performance.

Footnotes indicate options vest in three equal annual tranches, and performance stock units vest in full after three years. This design ties realizable value to tenure and performance outcomes.

No cash proceeds to the issuer are disclosed here. Actual dilution and value realization depend on vesting and future stock performance; the excerpt provides no additional timing beyond the vesting schedules.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Riggsbee Richard Bryan

(Last) (First) (Middle)

620 LESHER PLACE

(Street)

LANSING MI 48912

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/03/2025		A		178,855(2)	A	$6.29	178,855	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock (Right to Buy)	$6.29	11/03/2025		A		459,713		(1)	11/03/2025	Common Stock	459,713	$0	459,713	D

Explanation of Responses:

1. Options vest in equal annual installments on each of the first three anniversary dates of the grants

2. PSUs vest in total at the end of the three year anniversary date of the grant

	Christopher Sefcheck (Attorney in Fact)	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NEOG’s CFO report?

The CFO reported acquiring 178,855 common shares and receiving 459,713 stock options on 11/03/2025.

What are the exercise price and size of the NEOG options grant?

The options cover 459,713 shares with an exercise price of $6.29.

How many NEOG shares does the CFO hold after the transaction?

Directly held common shares totaled 178,855 after the reported transaction.

What are the vesting terms for the options and PSUs at NEOG?

Options vest in three equal annual installments; PSUs vest in total at the end of the three-year anniversary of the grant.

What was the reported price for the NEOG common shares acquired?

The filing lists a price of $6.29 for the 178,855 common shares acquired.